Hong Kong Morning Sun
SEE OTHER BRANDS

The top news stories from Hong Kong

Hong Kong Morning Sun: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Hong Kong Morning Sun.

Press releases published on August 20, 2025

Tactica Asia Launches First AI-Powered B2B MarketPlace for Industrial Manufacturing

Tactica Asia Launches First AI-Powered B2B MarketPlace for Industrial Manufacturing

A new platform that removes barriers, strengthens supply chains, and accelerates adoption. HONG KONG, CHINA, August 20, 2025 /⁨EINPresswire.com⁩/ -- Tactica Asia, a leader in enterprise eProcurement and supply chain management solutions for over 18 years, …

Ecodeli by Asta Lok Wins Iron A' Design Award in Kitchenware and Horeca Category

Ecodeli by Asta Lok Wins Iron A' Design Award in Kitchenware and Horeca Category

Asta Lok's Innovative Silicone Meal Purse, Ecodeli, Receives Prestigious Recognition at the A' Design Award Competition COMO, CO, ITALY, August 20, 2025 /⁨EINPresswire.com⁩/ -- The A' Design Award, a highly respected and well-recognized award in the field …

XS.com獲頒模里西斯新牌照,持續推進全球合規佈局

XS.com獲頒模里西斯新牌照,持續推進全球合規佈局

TAIWAN, August 20, 2025 /⁨Business News⁩/ -- 全球領先的金融科技與金融服務提供者 XS.com 今日宣佈,已獲模里西斯金融服務委員會(FSC)核發的牌照。 這一戰略性進展標誌著XS.com的又一重要里程碑。自2010年在澳洲成立以來,這家全球多資產經紀商始終堅持嚴格的合規要求與卓越的客戶服務,如今透過在模里西斯設立持牌實體,再次展現其始終如一的堅定承諾。 新牌照的獲得將進一步提升XS.com服務全球客戶群的能力,與其國際化發展的戰略願景完美契合。 …

HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China

HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces the completion of patient enrollment of SANOVO, a China Phase III study of ORPATHYS® ( …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions